Screener
Vir Biotechnology, Inc. VIR Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalents.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s restricted cash?
- Vir Biotechnology, Inc. (VIR) reported restricted cash of $8.9M in Q2 2026.
- How has Vir Biotechnology, Inc.'s restricted cash changed year-over-year?
- Vir Biotechnology, Inc.'s restricted cash decreased by 90.7% year-over-year, from $95.2M to $8.9M.
- What is the long-term trend for Vir Biotechnology, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s restricted cash has grown at a -24.8% compound annual growth rate (CAGR), from $7.99M to $1.92M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Vir Biotechnology, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude